Discover more from Igor’s Newsletter
Did Molnupiravir Create the Recent "COVID Variant Soup"?
Glad that Merck Made Some Money Though
There are two Covid-specific drugs. One is Paxlovid, developed by Pfizer, which causes “Paxlovid rebounds” and was not tested by Pfizer on vaccinated people. I wrote about a dozen articles on it, exposing it as snake oil, and this one is a good summary.
Another is Molnupiravir, which has a very interesting mode of action. It interferes with viral replication, CAUSING AN EXCESSIVE AMOUNT OF MUTATIONS, so much that the mutated viral descendants are essentially defective and cannot replicate.
However, the problem is that SOME mutated copies CAN replicate — and cause excessive generation of “Covid variants” — a so-called “variant soup.”
Ryan Hisner explains how some variants, such as BM.2, have an unusually high amount of mutations.
This is what the current variant soup looks like:
We did discuss how Covid possibly was lab-enhanced to create variants:
However, in the past, it used to be just a few variants competing and one variant being on top. What has been happening since this fall is that we have a total mess of variants on top of variants chasing each other.
Could this be due to the mutagenic effects of Molnupiravir?
Is Molnupiravir Also Mutagenic for HUMAN DNA?
About a year ago, Brian Mowrey asked this question, and if you are interested in his very technical take, please take a look here:
Modern Discontent analyzes rebounds from Molnupiravir here:
This post is intended to solicit other people’s thoughts, and I hope we will continue this discussion in the comments or other substackers’ posts.
What do you think? Could Molnupiravir enhance the generation of new Covid variants? Is it responsible for the “variant soup” we are observing?